Parisé H - Search Results

1

Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched cohort study.

Gradman AH, Parisé H, Lefebvre P, Falvey H, Lafeuille MH, Duh MS. Gradman AH, et al. Among authors: parise h. Hypertension. 2013 Feb;61(2):309-18. doi: 10.1161/HYPERTENSIONAHA.112.201566. Epub 2012 Nov 26. Hypertension. 2013. PMID: 23184383

2

Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization.

Manjunath R, Paradis PE, Parisé H, Lafeuille MH, Bowers B, Duh MS, Lefebvre P, Faught E. Manjunath R, et al. Among authors: parise h. Neurology. 2012 Oct 30;79(18):1908-16. doi: 10.1212/WNL.0b013e318271f77e. Epub 2012 Oct 17. Neurology. 2012. PMID: 23077014

3

Association of self-monitoring of blood glucose use on glycated hemoglobin and weight in newly diagnosed, insulin-naïve adult patients with type 2 diabetes.

Virdi NS, Lefebvre P, Parisé H, Duh MS, Pilon D, Laliberté F, Sundaresan D, Garber L, Dirani R. Virdi NS, et al. Among authors: parise h. J Diabetes Sci Technol. 2013 Sep 1;7(5):1229-42. doi: 10.1177/193229681300700513. J Diabetes Sci Technol. 2013. PMID: 24124950 Free PMC article.

4

Direct and indirect cost burden associated with multiple sclerosis relapses: excess costs of persons with MS and their spouse caregivers.

Parisé H, Laliberté F, Lefebvre P, Duh MS, Kim E, Agashivala N, Abouzaid S, Weinstock-Guttman B. Parisé H, et al. J Neurol Sci. 2013 Jul 15;330(1-2):71-7. doi: 10.1016/j.jns.2013.04.007. Epub 2013 May 3. J Neurol Sci. 2013. PMID: 23647840

5

Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study.

Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA, Vasan RS, Levy D. Mitchell GF, et al. Among authors: parise h. Hypertension. 2004 Jun;43(6):1239-45. doi: 10.1161/01.HYP.0000128420.01881.aa. Epub 2004 May 3. Hypertension. 2004. PMID: 15123572

6

Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study.

Mitchell GF, Parise H, Vita JA, Larson MG, Warner E, Keaney JF Jr, Keyes MJ, Levy D, Vasan RS, Benjamin EJ. Mitchell GF, et al. Among authors: parise h. Hypertension. 2004 Aug;44(2):134-9. doi: 10.1161/01.HYP.0000137305.77635.68. Epub 2004 Jul 12. Hypertension. 2004. PMID: 15249547 Clinical Trial.

7

Alcohol-Mediated Renal Denervation Using the Peregrine System Infusion Catheter for Treatment of Hypertension.

Mahfoud F, Renkin J, Sievert H, Bertog S, Ewen S, Böhm M, Lengelé JP, Wojakowski W, Schmieder R, van der Giet M, Parise H, Haratani N, Pathak A, Persu A. Mahfoud F, et al. Among authors: parise h. JACC Cardiovasc Interv. 2020 Feb 24;13(4):471-484. doi: 10.1016/j.jcin.2019.10.048. JACC Cardiovasc Interv. 2020. PMID: 32081241 Free article.

8

Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study.

Fox CS, Vasan RS, Parise H, Levy D, O'Donnell CJ, D'Agostino RB, Benjamin EJ; Framingham Heart Study. Fox CS, et al. Among authors: parise h. Circulation. 2003 Mar 25;107(11):1492-6. doi: 10.1161/01.cir.0000058168.26163.bc. Circulation. 2003. PMID: 12654605

9

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Wilson PW, et al. Among authors: parise h. Arch Intern Med. 2002 Sep 9;162(16):1867-72. doi: 10.1001/archinte.162.16.1867. Arch Intern Med. 2002. PMID: 12196085

10

Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk factors, and aortic stiffness: the Framingham Heart Study.

Mitchell GF, Vita JA, Larson MG, Parise H, Keyes MJ, Warner E, Vasan RS, Levy D, Benjamin EJ. Mitchell GF, et al. Among authors: parise h. Circulation. 2005 Dec 13;112(24):3722-8. doi: 10.1161/CIRCULATIONAHA.105.551168. Epub 2005 Dec 5. Circulation. 2005. PMID: 16330686

11

Pulse pressure and risk of new-onset atrial fibrillation.

Mitchell GF, Vasan RS, Keyes MJ, Parise H, Wang TJ, Larson MG, D'Agostino RB Sr, Kannel WB, Levy D, Benjamin EJ. Mitchell GF, et al. Among authors: parise h. JAMA. 2007 Feb 21;297(7):709-15. doi: 10.1001/jama.297.7.709. JAMA. 2007. PMID: 17312290

12

Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham Heart Study.

Levy D, Hwang SJ, Kayalar A, Benjamin EJ, Vasan RS, Parise H, Larson MG, Wang TJ, Selhub J, Jacques PF, Vita JA, Keyes MJ, Mitchell GF. Levy D, et al. Among authors: parise h. Circulation. 2007 Jun 19;115(24):3079-85. doi: 10.1161/CIRCULATIONAHA.106.652842. Epub 2007 May 28. Circulation. 2007. PMID: 17533184

13

Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study.

Fox CS, Larson MG, Vasan RS, Guo CY, Parise H, Levy D, Leip EP, O'donnell CJ, D'Agostino RB Sr, Benjamin EJ. Fox CS, et al. Among authors: parise h. J Am Soc Nephrol. 2006 Feb;17(2):521-7. doi: 10.1681/ASN.2005060627. Epub 2005 Dec 28. J Am Soc Nephrol. 2006. PMID: 16382018

14

Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study.

Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB, Nesto RW, Wilson PW, Vasan RS. Rutter MK, et al. Among authors: parise h. Circulation. 2003 Jan 28;107(3):448-54. doi: 10.1161/01.cir.0000045671.62860.98. Circulation. 2003. PMID: 12551870

15

Mitral annular calcification is a predictor for incident atrial fibrillation.

Fox CS, Parise H, Vasan RS, Levy D, O'Donnell CJ, D'Agostino RB, Plehn JF, Benjamin EJ. Fox CS, et al. Among authors: parise h. Atherosclerosis. 2004 Apr;173(2):291-4. doi: 10.1016/j.atherosclerosis.2003.12.018. Atherosclerosis. 2004. PMID: 15064104

16

Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring.

Fox CS, Parise H, D'Agostino RB Sr, Lloyd-Jones DM, Vasan RS, Wang TJ, Levy D, Wolf PA, Benjamin EJ. Fox CS, et al. Among authors: parise h. JAMA. 2004 Jun 16;291(23):2851-5. doi: 10.1001/jama.291.23.2851. JAMA. 2004. PMID: 15199036

17

Obesity and the risk of new-onset atrial fibrillation.

Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS, Benjamin EJ. Wang TJ, et al. Among authors: parise h. JAMA. 2004 Nov 24;292(20):2471-7. doi: 10.1001/jama.292.20.2471. JAMA. 2004. PMID: 15562125

18

Relations of inflammation and novel risk factors to valvular calcification.

Fox CS, Guo CY, Larson MG, Vasan RS, Parise H, O'Donnell CJ, D'Agostino RB Sr, Keaney JF Jr, Benjamin EJ. Fox CS, et al. Among authors: parise h. Am J Cardiol. 2006 May 15;97(10):1502-5. doi: 10.1016/j.amjcard.2005.11.086. Epub 2006 Mar 29. Am J Cardiol. 2006. PMID: 16679093

19

Phenotype-genotype association grid: a convenient method for summarizing multiple association analyses.

Levy D, DePalma SR, Benjamin EJ, O'Donnell CJ, Parise H, Hirschhorn JN, Vasan RS, Izumo S, Larson MG. Levy D, et al. Among authors: parise h. BMC Genet. 2006 May 22;7:30. doi: 10.1186/1471-2156-7-30. BMC Genet. 2006. PMID: 16716207 Free PMC article.

20

Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension.

Mahfoud F, Sievert H, Bertog S, Lauder L, Ewen S, Lengelé JP, Wojakowski W, Schmieder R, van der Giet M, Weber MA, Kandzari DE, Parise H, Fischell TA, Pathak A, Persu A. Mahfoud F, et al. Among authors: parise h. Circ Cardiovasc Interv. 2021 Sep;14(9):e010075. doi: 10.1161/CIRCINTERVENTIONS.120.010075. Epub 2021 Sep 2. Circ Cardiovasc Interv. 2021. PMID: 34470501 Free PMC article.

21

Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications.

Mahfoud F, Weber M, Schmieder RE, Lobo MD, Blankestijn PJ, Persu A, Fischell TA, Parise H, Pathak A, Kandzari DE. Mahfoud F, et al. Among authors: parise h. Am Heart J. 2021 Sep;239:90-99. doi: 10.1016/j.ahj.2021.05.015. Epub 2021 May 27. Am Heart J. 2021. PMID: 34052211

22

Blood pressure lowering with alcohol-mediated renal denervation using the Peregrine infusion Catheter is independent of injection site location.

Mahfoud F, Bertog S, Lauder L, Böhm M, Schmid A, Wojakowski W, Parise H, Fischell TA, Kandzari DE, Pathak A, Persu A, Sievert H. Mahfoud F, et al. Among authors: parise h. Catheter Cardiovasc Interv. 2021 Nov 15;98(6):E832-E838. doi: 10.1002/ccd.29936. Epub 2021 Sep 2. Catheter Cardiovasc Interv. 2021. PMID: 34472656

23

Impact of drug adherence on blood pressure response to alcohol-mediated renal denervation.

Persu A, Maes F, Toennes SW, Ritscher S, Georges C, Wallemacq P, Haratani N, Parise H, Fischell TA, Lauder L, Mahfoud F. Persu A, et al. Among authors: parise h. Blood Press. 2022 Dec;31(1):109-117. doi: 10.1080/08037051.2022.2074367. Blood Press. 2022. PMID: 35575248

24

Evaluation of Transcatheter Alcohol-Mediated Perivascular Renal Denervation to Treat Resistant Hypertension.

Janas A, Król M, Hochuł M, Jochymczyk M, Hayward-Costa C, Parise H, Haratani N, Fischell T, Wojakowski W. Janas A, et al. Among authors: parise h. J Clin Med. 2020 Jun 16;9(6):1881. doi: 10.3390/jcm9061881. J Clin Med. 2020. PMID: 32560164 Free PMC article.

25

Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial.

Witzenbichler B, Mehran R, Guagliumi G, Dudek D, Huber K, Kornowski R, Stuckey TD, Fahy M, Parise H, Stone GW. Witzenbichler B, et al. Among authors: parise h. JACC Cardiovasc Interv. 2011 Jul;4(7):760-8. doi: 10.1016/j.jcin.2011.04.008. JACC Cardiovasc Interv. 2011. PMID: 21777884 Free article. Clinical Trial.

26

Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial.

Costa RA, Abizaid A, Mehran R, Schofer J, Schuler GC, Hauptmann KE, Magalhães MA, Parise H, Grube E; BioFreedom FIM Clinical Trial Investigators. Costa RA, et al. Among authors: parise h. JACC Cardiovasc Interv. 2016 Jan 11;9(1):51-64. doi: 10.1016/j.jcin.2015.09.008. JACC Cardiovasc Interv. 2016. PMID: 26762911 Free article. Clinical Trial.

27

Paclitaxel-eluting stents compared with bare metal stents in diabetic patients with acute myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.

Witzenbichler B, Wöhrle J, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Hood KL, Parise H, Lansky AJ, Nikolsky E, Mehran R, Stone GW. Witzenbichler B, et al. Among authors: parise h. Circ Cardiovasc Interv. 2011 Apr 1;4(2):130-8. doi: 10.1161/CIRCINTERVENTIONS.110.960245. Epub 2011 Mar 1. Circ Cardiovasc Interv. 2011. PMID: 21364152 Clinical Trial.

28

Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.

Yu J, Mehran R, Dangas GD, Claessen BE, Baber U, Xu K, Parise H, Fahy M, Lansky AJ, Witzenbichler B, Grines CL, Guagliumi G, Kornowski R, Wöhrle J, Dudek D, Weisz G, Stone GW. Yu J, et al. Among authors: parise h. JACC Cardiovasc Interv. 2012 Dec;5(12):1231-8. doi: 10.1016/j.jcin.2012.07.016. JACC Cardiovasc Interv. 2012. PMID: 23257371 Free article. Clinical Trial.

29

Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials.

Mehran R, Pocock S, Nikolsky E, Dangas GD, Clayton T, Claessen BE, Caixeta A, Feit F, Manoukian SV, White H, Bertrand M, Ohman EM, Parise H, Lansky AJ, Lincoff AM, Stone GW. Mehran R, et al. Among authors: parise h. JACC Cardiovasc Interv. 2011 Jun;4(6):654-64. doi: 10.1016/j.jcin.2011.02.011. JACC Cardiovasc Interv. 2011. PMID: 21700252 Free article.

30

The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent.

Haude M, Lee SW, Worthley SG, Silber S, Verheye S, Erbs S, Rosli MA, Botelho R, Meredith I, Sim KH, Stella PR, Tan HC, Whitbourn R, Thambar S, Abizaid A, Koh TH, Den Heijer P, Parise H, Cristea E, Maehara A, Mehran R. Haude M, et al. Among authors: parise h. JACC Cardiovasc Interv. 2013 Apr;6(4):334-43. doi: 10.1016/j.jcin.2012.10.018. Epub 2013 Mar 20. JACC Cardiovasc Interv. 2013. PMID: 23523459 Free article. Clinical Trial.

31

Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes.

Dangas GD, Claessen BE, Mehran R, Xu K, Fahy M, Parise H, Henriques JP, Ohman EM, White HD, Stone GW. Dangas GD, et al. Among authors: parise h. JACC Cardiovasc Interv. 2012 Nov;5(11):1097-105. doi: 10.1016/j.jcin.2012.07.012. JACC Cardiovasc Interv. 2012. PMID: 23174632 Free article.

32

The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.

Wu X, Mintz GS, Xu K, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA Jr, Dressler O, Parise H, Mehran R, Stone GW, Maehara A. Wu X, et al. Among authors: parise h. JACC Cardiovasc Interv. 2011 May;4(5):495-502. doi: 10.1016/j.jcin.2010.12.012. JACC Cardiovasc Interv. 2011. PMID: 21596321 Free article.

33

Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.

Brener SJ, Maehara A, Dizon JM, Fahy M, Witzenbichler B, Parise H, El-Omar M, Dambrink JH, Mehran R, Oldroyd K, Gibson CM, Stone GW. Brener SJ, et al. Among authors: parise h. JACC Cardiovasc Interv. 2013 Jul;6(7):718-24. doi: 10.1016/j.jcin.2013.03.013. JACC Cardiovasc Interv. 2013. PMID: 23866184 Free article. Clinical Trial.

34

Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.

Claessen BE, Smits PC, Kereiakes DJ, Parise H, Fahy M, Kedhi E, Serruys PW, Lansky AJ, Cristea E, Sudhir K, Sood P, Simonton CA, Stone GW. Claessen BE, et al. Among authors: parise h. JACC Cardiovasc Interv. 2011 Nov;4(11):1209-15. doi: 10.1016/j.jcin.2011.07.016. JACC Cardiovasc Interv. 2011. PMID: 22115661 Free article.

35

Long-term follow-up of attenuated plaques in patients with acute myocardial infarction: an intravascular ultrasound substudy of the HORIZONS-AMI trial.

Xu K, Mintz GS, Kubo T, Wu X, Guo N, Yang J, Witzenbichler B, Guagliumi G, Brodie B, Dressler O, Cristea E, Parise H, Mehran R, Stone GW, Maehara A. Xu K, et al. Among authors: parise h. Circ Cardiovasc Interv. 2012 Apr;5(2):185-92. doi: 10.1161/CIRCINTERVENTIONS.111.964684. Epub 2012 Mar 20. Circ Cardiovasc Interv. 2012. PMID: 22438429 Clinical Trial.

36

Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.

Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Ochala A, Kellock A, Parise H, Mehran R; HORIZONS-AMI Trial Investigators. Stone GW, et al. Among authors: parise h. N Engl J Med. 2009 May 7;360(19):1946-59. doi: 10.1056/NEJMoa0810116. N Engl J Med. 2009. PMID: 19420364 Free article. Clinical Trial.

37

Dynamic nature of nonculprit coronary artery lesion morphology in STEMI: a serial IVUS analysis from the HORIZONS-AMI trial.

Zhao Z, Witzenbichler B, Mintz GS, Jaster M, Choi SY, Wu X, He Y, Margolis MP, Dressler O, Cristea E, Parise H, Mehran R, Stone GW, Maehara A. Zhao Z, et al. Among authors: parise h. JACC Cardiovasc Imaging. 2013 Jan;6(1):86-95. doi: 10.1016/j.jcmg.2012.08.010. JACC Cardiovasc Imaging. 2013. PMID: 23328566 Free article. Clinical Trial.

38

Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.

Farkouh ME, Reiffel J, Dressler O, Nikolsky E, Parise H, Cristea E, Baran DA, Dizon J, Merab JP, Lansky AJ, Mehran R, Stone GW. Farkouh ME, et al. Among authors: parise h. Circ Cardiovasc Interv. 2013 Jun;6(3):216-23. doi: 10.1161/CIRCINTERVENTIONS.112.000142. Epub 2013 May 7. Circ Cardiovasc Interv. 2013. PMID: 23652600 Clinical Trial.

39

Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study.

Roubenoff R, Parise H, Payette HA, Abad LW, D'Agostino R, Jacques PF, Wilson PW, Dinarello CA, Harris TB. Roubenoff R, et al. Among authors: parise h. Am J Med. 2003 Oct 15;115(6):429-35. doi: 10.1016/j.amjmed.2003.05.001. Am J Med. 2003. PMID: 14563498

40

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus.

Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Wilson PW, et al. Among authors: parise h. Circulation. 2005 Nov 15;112(20):3066-72. doi: 10.1161/CIRCULATIONAHA.105.539528. Epub 2005 Nov 7. Circulation. 2005. PMID: 16275870

41

Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study.

Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H, D'Agostino RB, Wilson PW, Schaefer EJ. Freedman DS, et al. Among authors: parise h. Clin Chem. 2004 Jul;50(7):1189-200. doi: 10.1373/clinchem.2004.032763. Epub 2004 Apr 23. Clin Chem. 2004. PMID: 15107310

42

A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation.

Abraham WT, Kuck KH, Goldsmith RL, Lindenfeld J, Reddy VY, Carson PE, Mann DL, Saville B, Parise H, Chan R, Wiegn P, Hastings JL, Kaplan AJ, Edelmann F, Luthje L, Kahwash R, Tomassoni GF, Gutterman DD, Stagg A, Burkhoff D, Hasenfuß G. Abraham WT, et al. Among authors: parise h. JACC Heart Fail. 2018 Oct;6(10):874-883. doi: 10.1016/j.jchf.2018.04.010. Epub 2018 May 10. JACC Heart Fail. 2018. PMID: 29754812 Free article. Clinical Trial.

43

Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registry.

Baber U, Mehran R, Kirtane AJ, Gurbel PA, Christodoulidis G, Maehara A, Witzenbichler B, Weisz G, Rinaldi MJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Xu K, Parise H, Brodie BR, Stuckey TD, Stone GW. Baber U, et al. Among authors: parise h. Circ Cardiovasc Interv. 2015 Jun;8(6):e001683. doi: 10.1161/CIRCINTERVENTIONS.115.001683. Circ Cardiovasc Interv. 2015. PMID: 26056248

44

Bivalirudin during primary PCI in acute myocardial infarction.

Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R; HORIZONS-AMI Trial Investigators. Stone GW, et al. Among authors: parise h. N Engl J Med. 2008 May 22;358(21):2218-30. doi: 10.1056/NEJMoa0708191. N Engl J Med. 2008. PMID: 18499566 Free article. Clinical Trial.

45

Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.

Stone GW, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri E, Gurbel PA, Xu K, Parise H, Kirtane AJ, Brodie BR, Mehran R, Stuckey TD; ADAPT-DES Investigators. Stone GW, et al. Among authors: parise h. Lancet. 2013 Aug 17;382(9892):614-23. doi: 10.1016/S0140-6736(13)61170-8. Epub 2013 Jul 26. Lancet. 2013. PMID: 23890998 Clinical Trial.

46

Coronary orbital atherectomy treatment of Hispanic and Latino patients: A real-world comparative analysis.

Beohar N, Stone GW, Martinsen BJ, Parise H, Vinardell JM, Heimowitz T, Koelbl C, Leon MB, Kirtane AJ. Beohar N, et al. Among authors: parise h. Catheter Cardiovasc Interv. 2022 May;99(6):1752-1757. doi: 10.1002/ccd.30158. Epub 2022 Mar 21. Catheter Cardiovasc Interv. 2022. PMID: 35312163 Free PMC article.

47

Prognostic utility of myocardial blush grade after PCI in patients with NSTE-ACS: Analysis from the ACUITY trial.

Ng VG, Lansky AJ, Toro S, Parise H, Cristea E, Mehran R, Stone GW. Ng VG, et al. Among authors: parise h. Catheter Cardiovasc Interv. 2016 Aug;88(2):215-24. doi: 10.1002/ccd.25865. Epub 2015 Nov 18. Catheter Cardiovasc Interv. 2016. PMID: 25641255 Clinical Trial.

48

Impact of major bleeding and blood transfusions after cardiac surgery: analysis from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial.

Stone GW, Clayton TC, Mehran R, Dangas G, Parise H, Fahy M, Pocock SJ. Stone GW, et al. Among authors: parise h. Am Heart J. 2012 Mar;163(3):522-9. doi: 10.1016/j.ahj.2011.11.016. Am Heart J. 2012. PMID: 22424026 Clinical Trial.

49

Comparative effectiveness of upstream glycoprotein IIb/IIIa inhibitors in patients with moderate- and high-risk acute coronary syndromes: an Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudy.

Nazif TM, Mehran R, Lee EA, Fahy M, Parise H, Stone GW, Kirtane AJ. Nazif TM, et al. Among authors: parise h. Am Heart J. 2014 Jan;167(1):43-50. doi: 10.1016/j.ahj.2013.10.013. Epub 2013 Oct 19. Am Heart J. 2014. PMID: 24332141 Clinical Trial.

50

Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial.

Aoki J, Lansky AJ, Mehran R, Moses J, Bertrand ME, McLaurin BT, Cox DA, Lincoff AM, Ohman EM, White HD, Parise H, Leon MB, Stone GW. Aoki J, et al. Among authors: parise h. Circulation. 2009 Feb 10;119(5):687-98. doi: 10.1161/CIRCULATIONAHA.108.804203. Epub 2009 Jan 26. Circulation. 2009. PMID: 19171852 Clinical Trial.

51

Volumetric intravascular ultrasound analysis of Paclitaxel-eluting and bare metal stents in acute myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy.

Maehara A, Mintz GS, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA Jr, Parise H, Mehran R, Stone GW. Maehara A, et al. Among authors: parise h. Circulation. 2009 Nov 10;120(19):1875-82. doi: 10.1161/CIRCULATIONAHA.109.873893. Epub 2009 Oct 26. Circulation. 2009. PMID: 19858413 Clinical Trial.

52

Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.

Guo N, Maehara A, Mintz GS, He Y, Xu K, Wu X, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA Jr, Dressler O, Parise H, Mehran R, Stone GW. Guo N, et al. Among authors: parise h. Circulation. 2010 Sep 14;122(11):1077-84. doi: 10.1161/CIRCULATIONAHA.109.906040. Epub 2010 Aug 30. Circulation. 2010. PMID: 20805433 Clinical Trial.

53

Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.

Stone GW, Parise H, Witzenbichler B, Kirtane A, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Lansky AJ, Mehran R. Stone GW, et al. Among authors: parise h. J Am Coll Cardiol. 2010 Nov 2;56(19):1597-604. doi: 10.1016/j.jacc.2010.08.608. Epub 2010 Oct 1. J Am Coll Cardiol. 2010. PMID: 20888162 Free article. Clinical Trial.

54

Impact of transfer for primary percutaneous coronary intervention on survival and clinical outcomes (from the HORIZONS-AMI Trial).

Wöhrle J, Desaga M, Metzger C, Huber K, Suryapranata H, Guetta V, Guagliumi G, Witzenbichler B, Parise H, Mehran R, Stone GW. Wöhrle J, et al. Among authors: parise h. Am J Cardiol. 2010 Nov 1;106(9):1218-24. doi: 10.1016/j.amjcard.2010.06.049. Epub 2010 Sep 9. Am J Cardiol. 2010. PMID: 21029816 Clinical Trial.

55

Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial.

Guagliumi G, Costa MA, Sirbu V, Musumeci G, Bezerra HG, Suzuki N, Matiashvili A, Lortkipanidze N, Mihalcsik L, Trivisonno A, Valsecchi O, Mintz GS, Dressler O, Parise H, Maehara A, Cristea E, Lansky AJ, Mehran R, Stone GW. Guagliumi G, et al. Among authors: parise h. Circulation. 2011 Jan 25;123(3):274-81. doi: 10.1161/CIRCULATIONAHA.110.963181. Epub 2011 Jan 10. Circulation. 2011. PMID: 21220730 Clinical Trial.

56

Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.

Dangas GD, Caixeta A, Mehran R, Parise H, Lansky AJ, Cristea E, Brodie BR, Witzenbichler B, Guagliumi G, Peruga JZ, Dudek D, Möeckel M, Stone GW; Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial Investigators. Dangas GD, et al. Among authors: parise h. Circulation. 2011 Apr 26;123(16):1745-56. doi: 10.1161/CIRCULATIONAHA.110.981688. Epub 2011 Apr 11. Circulation. 2011. PMID: 21482968 Clinical Trial.

57

Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy.

Choi SY, Witzenbichler B, Maehara A, Lansky AJ, Guagliumi G, Brodie B, Kellett MA Jr, Dressler O, Parise H, Mehran R, Dangas GD, Mintz GS, Stone GW. Choi SY, et al. Among authors: parise h. Circ Cardiovasc Interv. 2011 Jun;4(3):239-47. doi: 10.1161/CIRCINTERVENTIONS.110.959791. Epub 2011 May 17. Circ Cardiovasc Interv. 2011. PMID: 21586693 Clinical Trial.

58

Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trial.

Palmerini T, Mehran R, Dangas G, Nikolsky E, Witzenbichler B, Guagliumi G, Dudek D, Genereux P, Caixeta A, Rabbani L, Weisz G, Parise H, Fahy M, Xu K, Brodie B, Lansky A, Stone GW. Palmerini T, et al. Among authors: parise h. Circulation. 2011 Jun 21;123(24):2829-37, 7 p following 2837. doi: 10.1161/CIRCULATIONAHA.110.985564. Epub 2011 May 31. Circulation. 2011. PMID: 21632496 Clinical Trial.

59

Comparison of direct stenting with conventional stent implantation in acute myocardial infarction.

Möckel M, Vollert J, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Kornowski R, Dudek D, Farkouh ME, Parise H, Mehran R, Stone GW; Horizons-AMI Trial Investigators. Möckel M, et al. Among authors: parise h. Am J Cardiol. 2011 Dec 15;108(12):1697-703. doi: 10.1016/j.amjcard.2011.07.040. Epub 2011 Sep 8. Am J Cardiol. 2011. PMID: 21906709 Clinical Trial.

60

Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.

Suh JW, Mehran R, Claessen BE, Xu K, Baber U, Dangas G, Parise H, Lansky AJ, Witzenbichler B, Grines CL, Guagliumi G, Kornowski R, Wöhrle J, Dudek D, Weisz G, Stone GW. Suh JW, et al. Among authors: parise h. J Am Coll Cardiol. 2011 Oct 18;58(17):1750-6. doi: 10.1016/j.jacc.2011.07.021. J Am Coll Cardiol. 2011. PMID: 21996385 Free article.

61

Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).

Nikolsky E, Mehran R, Dangas GD, Yu J, Parise H, Xu K, Pocock SJ, Stone GW. Nikolsky E, et al. Among authors: parise h. Am J Cardiol. 2012 Mar 15;109(6):831-8. doi: 10.1016/j.amjcard.2011.10.046. Epub 2011 Dec 22. Am J Cardiol. 2012. PMID: 22196778 Clinical Trial.

62

Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study.

Witzenbichler B, Maehara A, Weisz G, Neumann FJ, Rinaldi MJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Stuckey TD, Mazzaferri EL Jr, Xu K, Parise H, Mehran R, Mintz GS, Stone GW. Witzenbichler B, et al. Among authors: parise h. Circulation. 2014 Jan 28;129(4):463-70. doi: 10.1161/CIRCULATIONAHA.113.003942. Epub 2013 Nov 26. Circulation. 2014. PMID: 24281330 Clinical Trial.

63

The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale.

Mehran R, Brodie B, Cox DA, Grines CL, Rutherford B, Bhatt DL, Dangas G, Feit F, Ohman EM, Parise H, Fahy M, Lansky AJ, Stone GW. Mehran R, et al. Among authors: parise h. Am Heart J. 2008 Jul;156(1):44-56. doi: 10.1016/j.ahj.2008.02.008. Am Heart J. 2008. PMID: 18585496 Clinical Trial.

64

5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.

Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R. Caixeta A, et al. Among authors: parise h. J Am Coll Cardiol. 2009 Sep 1;54(10):894-902. doi: 10.1016/j.jacc.2009.04.077. J Am Coll Cardiol. 2009. PMID: 19712798 Free article.

65

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial.

Mehran R, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Wong SC, Nikolsky E, Gambone L, Vandertie L, Parise H, Dangas GD, Stone GW; HORIZONS-AMI Trial Investigators. Mehran R, et al. Among authors: parise h. Lancet. 2009 Oct 3;374(9696):1149-59. doi: 10.1016/S0140-6736(09)61484-7. Epub 2009 Aug 28. Lancet. 2009. PMID: 19717185 Clinical Trial.

66

Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.

Dangas G, Mehran R, Guagliumi G, Caixeta A, Witzenbichler B, Aoki J, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Rabbani LE, Parise H, Stone GW; HORIZONS-AMI Trial Investigators. Dangas G, et al. Among authors: parise h. J Am Coll Cardiol. 2009 Oct 6;54(15):1438-46. doi: 10.1016/j.jacc.2009.06.021. J Am Coll Cardiol. 2009. PMID: 19796737 Free article. Clinical Trial.

67

Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial.

Pocock SJ, Mehran R, Clayton TC, Nikolsky E, Parise H, Fahy M, Lansky AJ, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Stone GW. Pocock SJ, et al. Among authors: parise h. Circulation. 2010 Jan 5;121(1):43-51. doi: 10.1161/CIRCULATIONAHA.109.878017. Epub 2009 Dec 21. Circulation. 2010. PMID: 20026777

68

Serial intravascular ultrasound analysis of the impact of myocardial bridge on neointimal proliferation after coronary stenting in patients with acute myocardial infarction.

Tsujita K, Maehara A, Mintz GS, Lansky AJ, Kubo T, Doi H, Yang J, Bharaj H, Witzenbichler B, Guagliumi G, Brodie BR, Kellett MA Jr, Parise H, Mehran R, Stone GW. Tsujita K, et al. Among authors: parise h. J Interv Cardiol. 2010 Apr;23(2):114-22. doi: 10.1111/j.1540-8183.2010.00531.x. Epub 2010 Mar 2. J Interv Cardiol. 2010. PMID: 20236216 Free article. Clinical Trial.

69

Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial.

Lansky AJ, Goto K, Cristea E, Fahy M, Parise H, Feit F, Ohman EM, White HD, Alexander KP, Bertrand ME, Desmet W, Hamon M, Mehran R, Moses J, Leon M, Stone GW. Lansky AJ, et al. Among authors: parise h. Circ Cardiovasc Interv. 2010 Aug;3(4):308-16. doi: 10.1161/CIRCINTERVENTIONS.109.887604. Epub 2010 Jul 20. Circ Cardiovasc Interv. 2010. PMID: 20647564 Clinical Trial.

70

When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials.

Brodie BR, Gersh BJ, Stuckey T, Witzenbichler B, Guagliumi G, Peruga JZ, Dudek D, Grines CL, Cox D, Parise H, Prasad A, Lansky AJ, Mehran R, Stone GW. Brodie BR, et al. Among authors: parise h. J Am Coll Cardiol. 2010 Jul 27;56(5):407-13. doi: 10.1016/j.jacc.2010.04.020. J Am Coll Cardiol. 2010. PMID: 20650362 Free article. Clinical Trial.

71

Intravascular ultrasound findings of stent fractures in patients with Sirolimus- and Paclitaxel-eluting stents.

Doi H, Maehara A, Mintz GS, Tsujita K, Kubo T, Castellanos C, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA Jr, Parise H, Mehran R, Leon MB, Moses JW, Stone GW. Doi H, et al. Among authors: parise h. Am J Cardiol. 2010 Oct 1;106(7):952-7. doi: 10.1016/j.amjcard.2010.05.024. Epub 2010 Aug 11. Am J Cardiol. 2010. PMID: 20854956

72

Predictors of reperfusion delay in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention from the HORIZONS-AMI trial.

Blankenship JC, Skelding KA, Scott TD, Berger PB, Parise H, Brodie BR, Witzenbichler B, Gaugliumi G, Peruga JZ, Lansky AJ, Mehran R, Stone GW. Blankenship JC, et al. Among authors: parise h. Am J Cardiol. 2010 Dec 1;106(11):1527-33. doi: 10.1016/j.amjcard.2010.07.033. Epub 2010 Oct 14. Am J Cardiol. 2010. PMID: 21094350 Clinical Trial.

73

Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis.

Dangas GD, Mehran R, Nikolsky E, Claessen BE, Lansky AJ, Brodie BR, Witzenbichler B, Guagliumi G, Peruga JZ, Dudek D, Möckel M, Caixeta A, Parise H, White H, Stone GW; HORIZONS-AMI Trial Investigators. Dangas GD, et al. Among authors: parise h. J Am Coll Cardiol. 2011 Jun 7;57(23):2309-16. doi: 10.1016/j.jacc.2011.01.038. J Am Coll Cardiol. 2011. PMID: 21636031 Free article. Clinical Trial.

74

Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus.

Stone GW, Kedhi E, Kereiakes DJ, Parise H, Fahy M, Serruys PW, Smits PC. Stone GW, et al. Among authors: parise h. Circulation. 2011 Aug 23;124(8):893-900. doi: 10.1161/CIRCULATIONAHA.111.031070. Epub 2011 Aug 8. Circulation. 2011. PMID: 21824922

75

Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial).

Goto K, Nikolsky E, Lansky AJ, Dangas G, Witzenbichler B, Parise H, Guagliumi G, Kornowski R, Claessen BE, Fahy M, Mehran R, Stone GW. Goto K, et al. Among authors: parise h. Am J Cardiol. 2011 Nov 15;108(10):1387-94. doi: 10.1016/j.amjcard.2011.06.063. Epub 2011 Aug 23. Am J Cardiol. 2011. PMID: 21864816 Clinical Trial.

76

Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS-AMI Trial IVUS substudy).

Choi SY, Maehara A, Cristea E, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA Jr, Dressler O, Lansky AJ, Parise H, Mehran R, Mintz GS, Stone GW. Choi SY, et al. Among authors: parise h. Am J Cardiol. 2012 Feb 15;109(4):455-60. doi: 10.1016/j.amjcard.2011.10.005. Epub 2011 Nov 24. Am J Cardiol. 2012. PMID: 22118823 Clinical Trial.

77

Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.

Rosner GF, Kirtane AJ, Genereux P, Lansky AJ, Cristea E, Gersh BJ, Weisz G, Parise H, Fahy M, Mehran R, Stone GW. Rosner GF, et al. Among authors: parise h. Circulation. 2012 May 29;125(21):2613-20. doi: 10.1161/CIRCULATIONAHA.111.069237. Epub 2012 May 1. Circulation. 2012. PMID: 22550156 Clinical Trial.

78

Plaque shift and distal embolism in patients with acute myocardial infarction: a volumetric intravascular ultrasound analysis from the HORIZONS-AMI trial.

Wu X, Maehara A, He Y, Xu K, Oviedo C, Witzenbichler B, Lansky AJ, Dressler O, Parise H, Stone GW, Mintz GS. Wu X, et al. Among authors: parise h. Catheter Cardiovasc Interv. 2013 Aug 1;82(2):203-9. doi: 10.1002/ccd.24644. Epub 2013 Mar 25. Catheter Cardiovasc Interv. 2013. PMID: 22936619

79

Characteristics and outcomes of patients with ST-segment elevation myocardial infarction excluded from the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) trial.

Fiocca L, Guagliumi G, Rossini R, Parise H, Musumeci G, Sirbu V, Lortkipanidze N, Yu J, Mihalcsik L, Vassileva A, Valsecchi O, Gavazzi A, Mehran R, Stone GW. Fiocca L, et al. Among authors: parise h. Am J Cardiol. 2013 Jan 15;111(2):196-201. doi: 10.1016/j.amjcard.2012.09.019. Epub 2012 Oct 27. Am J Cardiol. 2013. PMID: 23111141 Clinical Trial.

80

Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial).

Larsen AI, Nilsen DW, Yu J, Mehran R, Nikolsky E, Lansky AJ, Caixeta A, Parise H, Fahy M, Cristea E, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Stone GW. Larsen AI, et al. Among authors: parise h. Am J Cardiol. 2013 Mar 1;111(5):643-8. doi: 10.1016/j.amjcard.2012.11.011. Epub 2012 Dec 19. Am J Cardiol. 2013. PMID: 23261001 Clinical Trial.

81

Impact of bivalirudin and paclitaxel-eluting stents on outcomes in patients undergoing primary percutaneous coronary intervention of the left anterior descending artery.

Wöhrle J, Brodie B, Witzenbichler B, Dudek D, Kornowski R, Metzger C, Grines C, McAndrew TC, Parise H, Sergie Z, Mehran R, Stone GW. Wöhrle J, et al. Among authors: parise h. Am J Cardiol. 2013 Sep 15;112(6):753-60. doi: 10.1016/j.amjcard.2013.05.006. Epub 2013 Jun 6. Am J Cardiol. 2013. PMID: 23746479 Clinical Trial.

82

Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: analysis from the HORIZONS-AMI trial.

Brener SJ, Dizon JM, Mehran R, Guerchicoff A, Lansky AJ, Farkouh M, Brodie B, Guagliumi G, Witzenbichler B, Fahy M, Parise H, Stone GW. Brener SJ, et al. Among authors: parise h. Am Heart J. 2013 Oct;166(4):676-83. doi: 10.1016/j.ahj.2013.07.025. Epub 2013 Sep 13. Am Heart J. 2013. PMID: 24093847 Clinical Trial.

83

Body mass index and acute and long-term outcomes after acute myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial).

Herrmann J, Gersh BJ, Goldfinger JZ, Witzenbichler B, Guagliumi G, Dudek D, Kornowski R, Brener SJ, Parise H, Fahy M, McAndrew TC, Stone GW, Mehran R. Herrmann J, et al. Among authors: parise h. Am J Cardiol. 2014 Jul 1;114(1):9-16. doi: 10.1016/j.amjcard.2014.03.057. Epub 2014 Apr 16. Am J Cardiol. 2014. PMID: 24846807 Clinical Trial.

84

Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial).

Lansky AJ, Mehran R, Cristea E, Parise H, Feit F, Ohman EM, White HD, Alexander KP, Bertrand ME, Desmet W, Hamon M, Stone GW. Lansky AJ, et al. Among authors: parise h. Am J Cardiol. 2009 May 1;103(9):1196-203. doi: 10.1016/j.amjcard.2009.01.030. Am J Cardiol. 2009. PMID: 19406258 Clinical Trial.

85

A risk score to predict bleeding in patients with acute coronary syndromes.

Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, Parise H, Fahy M, Manoukian SV, Feit F, Ohman ME, Witzenbichler B, Guagliumi G, Lansky AJ, Stone GW. Mehran R, et al. Among authors: parise h. J Am Coll Cardiol. 2010 Jun 8;55(23):2556-66. doi: 10.1016/j.jacc.2009.09.076. J Am Coll Cardiol. 2010. PMID: 20513595 Free article. Clinical Trial.

86

Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction.

Gibson CM, Maehara A, Lansky AJ, Wohrle J, Stuckey T, Dave R, Cox D, Grines C, Dudek D, Steg G, Parise H, Wolff SD, Cristea E, Stone GW. Gibson CM, et al. Among authors: parise h. Am Heart J. 2011 Mar;161(3):478-486.e7. doi: 10.1016/j.ahj.2010.10.006. Epub 2011 Jan 28. Am Heart J. 2011. PMID: 21392601 Clinical Trial.

87

SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements.

Généreux P, Palmerini T, Caixeta A, Cristea E, Mehran R, Sanchez R, Lazar D, Jankovic I, Corral MD, Dressler O, Fahy MP, Parise H, Lansky AJ, Stone GW. Généreux P, et al. Among authors: parise h. Circ Cardiovasc Interv. 2011 Dec 1;4(6):553-61. doi: 10.1161/CIRCINTERVENTIONS.111.961862. Epub 2011 Oct 25. Circ Cardiovasc Interv. 2011. PMID: 22028472

88

Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial.

Stone GW, Maehara A, Witzenbichler B, Godlewski J, Parise H, Dambrink JH, Ochala A, Carlton TW, Cristea E, Wolff SD, Brener SJ, Chowdhary S, El-Omar M, Neunteufl T, Metzger DC, Karwoski T, Dizon JM, Mehran R, Gibson CM; INFUSE-AMI Investigators. Stone GW, et al. Among authors: parise h. JAMA. 2012 May 2;307(17):1817-26. doi: 10.1001/jama.2012.421. Epub 2012 Mar 25. JAMA. 2012. PMID: 22447888 Clinical Trial.

89

Impact of scheduled angiographic follow-up in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Mindrescu C, Brener SJ, Guerchicoff A, Fahy M, Parise H, Mehran R, Stone GW. Mindrescu C, et al. Among authors: parise h. J Interv Cardiol. 2013 Aug;26(4):319-24. doi: 10.1111/joic.12038. Epub 2013 Jun 24. J Interv Cardiol. 2013. PMID: 23795656 Free article. Clinical Trial.

90

Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial.

Brener SJ, Witzenbichler B, Maehara A, Dizon J, Fahy M, El-Omar M, Dambrink JH, Genereux P, Mehran R, Oldroyd K, Parise H, Gibson CM, Stone GW. Brener SJ, et al. Among authors: parise h. Am Heart J. 2013 Jul;166(1):64-70. doi: 10.1016/j.ahj.2013.03.029. Epub 2013 Apr 30. Am Heart J. 2013. PMID: 23816023 Clinical Trial.

91

Impact of coronary lesion complexity on drug-eluting stent outcomes in patients with and without diabetes mellitus: analysis from 18 pooled randomized trials.

Kedhi E, Généreux P, Palmerini T, McAndrew TC, Parise H, Mehran R, Dangas GD, Stone GW. Kedhi E, et al. Among authors: parise h. J Am Coll Cardiol. 2014 May 27;63(20):2111-2118. doi: 10.1016/j.jacc.2014.01.064. Epub 2014 Mar 13. J Am Coll Cardiol. 2014. PMID: 24632279 Free article. Clinical Trial.

92

Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.

Kim YH, Dangas GD, Solinas E, Aoki J, Parise H, Kimura M, Franklin-Bond T, Dasgupta NK, Kirtane AJ, Moussa I, Lansky AJ, Collins M, Stone GW, Leon MB, Moses JW, Mehran R. Kim YH, et al. Among authors: parise h. Am J Cardiol. 2008 Mar 15;101(6):801-6. doi: 10.1016/j.amjcard.2007.10.052. Epub 2008 Jan 18. Am J Cardiol. 2008. PMID: 18328844

93

Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials.

Kereiakes DJ, Smits PC, Kedhi E, Parise H, Fahy M, Serruys PW, Stone GW. Kereiakes DJ, et al. Among authors: parise h. EuroIntervention. 2011 May;7(1):74-83. doi: 10.4244/EIJV7I1A14. EuroIntervention. 2011. PMID: 21550906 Free article. Clinical Trial.

94

Clinical and angiographic evaluation of the resolute zotarolimus-eluting coronary stent in Japanese patients – long-term outcome in the RESOLUTE Japan and RESOLUTE Japan small vessel study.

Saito S, Maehara A, Vlachojannis GJ, Parise H, Mehran R; RESOLUTE Japan Investigators. Saito S, et al. Among authors: parise h. Circ J. 2015;79(1):96-103. doi: 10.1253/circj.CJ-14-0836. Epub 2014 Nov 27. Circ J. 2015. PMID: 25428602 Free article.

95

Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial.

Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Fahy M, Parise H, Mehran R; HORIZONS-AMI Trial Investigators. Stone GW, et al. Among authors: parise h. Lancet. 2011 Jun 25;377(9784):2193-204. doi: 10.1016/S0140-6736(11)60764-2. Epub 2011 Jun 12. Lancet. 2011. PMID: 21665265 Clinical Trial.

96

Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy).

Kirtane AJ, Parise H, Mehran R, Moses JW, Fahy M, Bertrand ME, Ohman EM, White HD, Feit F, Colombo A, McLaurin BT, Cox DA, Ware JH, Pocock SJ, Lansky AJ, Stone GW. Kirtane AJ, et al. Among authors: parise h. Am J Cardiol. 2010 Jul 15;106(2):180-6. doi: 10.1016/j.amjcard.2010.03.015. Am J Cardiol. 2010. PMID: 20599000 Clinical Trial.

97

A prospective natural-history study of coronary atherosclerosis.

Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW; PROSPECT Investigators. Stone GW, et al. Among authors: parise h. N Engl J Med. 2011 Jan 20;364(3):226-35. doi: 10.1056/NEJMoa1002358. N Engl J Med. 2011. PMID: 21247313 Free article. Clinical Trial.

98

Meta-analysis of randomized studies comparing intravascular ultrasound versus angiographic guidance of percutaneous coronary intervention in pre-drug-eluting stent era.

Parise H, Maehara A, Stone GW, Leon MB, Mintz GS. Parise H, et al. Am J Cardiol. 2011 Feb 1;107(3):374-82. doi: 10.1016/j.amjcard.2010.09.030. Am J Cardiol. 2011. PMID: 21257001

99

Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial).

Palmerini T, Brener SJ, Genereux P, Maehara A, Della Riva D, Mariani A, Witzenbichler B, Godlewski J, Parise H, Dambrink JH, Ochala A, Fahy M, Xu K, Gibson CM, Stone GW. Palmerini T, et al. Among authors: parise h. Am J Cardiol. 2013 Dec 15;112(12):1860-6. doi: 10.1016/j.amjcard.2013.08.010. Epub 2013 Sep 21. Am J Cardiol. 2013. PMID: 24063843 Clinical Trial.

100

Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial.

Dizon JM, Brener SJ, Maehara A, Witzenbichler B, Biviano A, Godlewski J, Parise H, Dambrink JH, Mehran R, Gibson CM, Stone GW. Dizon JM, et al. Among authors: parise h. Eur Heart J Acute Cardiovasc Care. 2014 Mar;3(1):78-83. doi: 10.1177/2048872613508658. Epub 2013 Oct 3. Eur Heart J Acute Cardiovasc Care. 2014. PMID: 24562806 Free PMC article. Clinical Trial.

101

Prognostic value of angiographic lesion complexity in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the acute catheterization and urgent intervention triage strategy trial).

Goto K, Lansky AJ, Ng VG, Pietras C, Nargileci E, Mehran R, Parise H, Feit F, Ohman EM, White HD, Bertrand ME, Desmet W, Hamon M, Stone GW. Goto K, et al. Among authors: parise h. Am J Cardiol. 2014 Dec 1;114(11):1638-45. doi: 10.1016/j.amjcard.2014.09.003. Epub 2014 Sep 18. Am J Cardiol. 2014. PMID: 25312637 Clinical Trial.

102

Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score.

Généreux P, Palmerini T, Caixeta A, Rosner G, Green P, Dressler O, Xu K, Parise H, Mehran R, Serruys PW, Stone GW. Généreux P, et al. Among authors: parise h. J Am Coll Cardiol. 2012 Jun 12;59(24):2165-74. doi: 10.1016/j.jacc.2012.03.010. Epub 2012 Apr 4. J Am Coll Cardiol. 2012. PMID: 22483327 Free PMC article.

103

Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials.

Kedhi E, Stone GW, Kereiakes DJ, Serruys PW, Parise H, Fahy M, Simonton CA, Sudhir K, Sood P, Smits PC. Kedhi E, et al. Among authors: parise h. EuroIntervention. 2012 Sep;8(5):599-606. doi: 10.4244/EIJV8I5A92. EuroIntervention. 2012. PMID: 22995087 Free article. Clinical Trial.

104

Relation of C-reactive protein levels to instability of untreated vulnerable coronary plaques (from the PROSPECT Study).

Kelly CR, Weisz G, Maehara A, Mintz GS, Mehran R, Lansky AJ, Parise H, de Bruyne B, Serruys PW, Stone GW. Kelly CR, et al. Among authors: parise h. Am J Cardiol. 2014 Aug 1;114(3):376-83. doi: 10.1016/j.amjcard.2014.04.048. Epub 2014 May 16. Am J Cardiol. 2014. PMID: 24931291

105

Simplified prediction of postoperative cardiac surgery outcomes with a novel score: R2CHADS2.

Peguero JG, Lo Presti S, Issa O, Podesta C, Parise H, Layka A, Brenes JC, Lamelas J, Lamas GA. Peguero JG, et al. Among authors: parise h. Am Heart J. 2016 Jul;177:153-9. doi: 10.1016/j.ahj.2016.04.019. Epub 2016 Apr 29. Am Heart J. 2016. PMID: 27297861

106

Coronary Orbital Atherectomy in Patients With Severe Aortic Stenosis.

Donatelle M, Agasthi P, Parise H, Igyarto Z, Martinsen BJ, Leon MB, Beohar N. Donatelle M, et al. Among authors: parise h. J Invasive Cardiol. 2022 Oct;34(10):E696-E700. J Invasive Cardiol. 2022. PMID: 36200995 Free article.

107

Comparison of the Absorbable Polymer Sirolimus-Eluting Stent (MiStent) to the Durable Polymer Everolimus-Eluting Stent (Xience) (from the DESSOLVE I/II and ISAR-TEST-4 Studies).

Lansky AJ, Kastrati A, Edelman ER, Parise H, Ng VG, Ormiston J, Wijns W, Byrne RA. Lansky AJ, et al. Among authors: parise h. Am J Cardiol. 2016 Feb 15;117(4):532-538. doi: 10.1016/j.amjcard.2015.11.044. Epub 2015 Dec 7. Am J Cardiol. 2016. PMID: 26762729 Free PMC article. Clinical Trial.

108

Impella Versus Intra-Aortic Balloon Pump for High-Risk PCI: A Propensity-Adjusted Large-Scale Claims Dataset Analysis.

Lansky AJ, Tirziu D, Moses JW, Pietras C, Ohman EM, O'Neill WW, Ekono MM, Grines CL, Parise H. Lansky AJ, et al. Among authors: parise h. Am J Cardiol. 2022 Dec 15;185:29-36. doi: 10.1016/j.amjcard.2022.08.032. Epub 2022 Oct 7. Am J Cardiol. 2022. PMID: 36210212 Free article.

109

Randomized Trial of Chocolate Touch Compared With Lutonix Drug-Coated Balloon in Femoropopliteal Lesions (Chocolate Touch Study).

Shishehbor MH, Zeller T, Werner M, Brodmann M, Parise H, Holden A, Lichtenberg M, Parikh SA, Kashyap VS, Pietras C, Tirziu D, Ardakani S, Beschorner U, Krishnan P, Niazi KA, Wali AU, Lansky AJ. Shishehbor MH, et al. Among authors: parise h. Circulation. 2022 May 31;145(22):1645-1654. doi: 10.1161/CIRCULATIONAHA.122.059646. Epub 2022 Apr 4. Circulation. 2022. PMID: 35377157 Clinical Trial.

110

A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial.

Lansky AJ, Schofer J, Tchetche D, Stella P, Pietras CG, Parise H, Abrams K, Forrest JK, Cleman M, Reinöhl J, Cuisset T, Blackman D, Bolotin G, Spitzer S, Kappert U, Gilard M, Modine T, Hildick-Smith D, Haude M, Margolis P, Brickman AM, Voros S, Baumbach A. Lansky AJ, et al. Among authors: parise h. Eur Heart J. 2015 Aug 14;36(31):2070-2078. doi: 10.1093/eurheartj/ehv191. Epub 2015 May 19. Eur Heart J. 2015. PMID: 25990342

111

Neurologic Complications of Unprotected Transcatheter Aortic Valve Implantation (from the Neuro-TAVI Trial).

Lansky AJ, Brown D, Pena C, Pietras CG, Parise H, Ng VG, Meller S, Abrams KJ, Cleman M, Margolis P, Petrossian G, Brickman AM, Voros S, Moses J, Forrest JK. Lansky AJ, et al. Among authors: parise h. Am J Cardiol. 2016 Nov 15;118(10):1519-1526. doi: 10.1016/j.amjcard.2016.08.013. Epub 2016 Aug 23. Am J Cardiol. 2016. PMID: 27645761 Clinical Trial.

112

A randomized evaluation of the TriGuard™ HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.

Lansky AJ, Makkar R, Nazif T, Messé S, Forrest J, Sharma R, Schofer J, Linke A, Brown D, Dhoble A, Horwitz P, Zang M, DeMarco F, Rajagopal V, Dwyer MG, Zivadinov R, Stella P, Rovin J, Parise H, Kodali S, Baumbach A, Moses J. Lansky AJ, et al. Among authors: parise h. Eur Heart J. 2021 Jul 15;42(27):2670-2679. doi: 10.1093/eurheartj/ehab213. Eur Heart J. 2021. PMID: 34000004 Clinical Trial.

113

Safety, Performance, and Efficacy of Cardiac Contractility Modulation Delivered by the 2-Lead Optimizer Smart System: The FIX-HF-5C2 Study.

Wiegn P, Chan R, Jost C, Saville BR, Parise H, Prutchi D, Carson PE, Stagg A, Goldsmith RL, Burkhoff D. Wiegn P, et al. Among authors: parise h. Circ Heart Fail. 2020 Apr;13(4):e006512. doi: 10.1161/CIRCHEARTFAILURE.119.006512. Epub 2020 Apr 8. Circ Heart Fail. 2020. PMID: 32264716 Free article.

114

Objective simulator-based evaluation of carotid artery stenting proficiency (from Assessment of Operator Performance by the Carotid Stenting Simulator Study [ASSESS]).

Weisz G, Smilowitz NR, Parise H, Devaud J, Moussa I, Ramee S, Reisman M, White CJ, Gray WA. Weisz G, et al. Among authors: parise h. Am J Cardiol. 2013 Jul 15;112(2):299-306. doi: 10.1016/j.amjcard.2013.02.069. Epub 2013 Apr 18. Am J Cardiol. 2013. PMID: 23601579

115

Design and rationale of the colchicine/statin for the prevention of COVID-19 complications (COLSTAT) trial.

Shah T, McCarthy M, Nasir I, Archer H, Ragheb E, Kluger J, Kashyap N, Paredes C, Patel P, Lu J, Kandel P, Song C, Khan M, Ul Haq F, Ahmad R, Howes C, Cambi B, Lancaster G, Cleman M, Dela Cruz CS, Parise H, Lansky A. Shah T, et al. Among authors: parise h. Contemp Clin Trials. 2021 Nov;110:106547. doi: 10.1016/j.cct.2021.106547. Epub 2021 Aug 28. Contemp Clin Trials. 2021. PMID: 34461322 Free PMC article. Clinical Trial.

116

A phenomapping-derived tool to personalize the selection of anatomical vs. functional testing in evaluating chest pain (ASSIST).

Oikonomou EK, Van Dijk D, Parise H, Suchard MA, de Lemos J, Antoniades C, Velazquez EJ, Miller EJ, Khera R. Oikonomou EK, et al. Among authors: parise h. Eur Heart J. 2021 Jul 8;42(26):2536-2548. doi: 10.1093/eurheartj/ehab223. Eur Heart J. 2021. PMID: 33881513 Free PMC article.

117

Compensatory post-diuretic renal sodium reabsorption is not a dominant mechanism of diuretic resistance in acute heart failure.

Cox ZL, Rao VS, Ivey-Miranda JB, Moreno-Villagomez J, Mahoney D, Ponikowski P, Biegus J, Turner JM, Maulion C, Bellumkonda L, Asher JL, Parise H, Wilson PF, Ellison DH, Wilcox CS, Testani JM. Cox ZL, et al. Among authors: parise h. Eur Heart J. 2021 Nov 14;42(43):4468-4477. doi: 10.1093/eurheartj/ehab620. Eur Heart J. 2021. PMID: 34529781 Free PMC article.

118

Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States.

Matasar M, Sanchez Alvarez J, Parisé H, Zuk E, Di Maio D, Shapouri S, Kim E, Lin SW. Matasar M, et al. Among authors: parise h. J Med Econ. 2024 May 7:1-36. doi: 10.1080/13696998.2024.2352820. Online ahead of print. J Med Econ. 2024. PMID: 38712895

119

Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results from the TARGET BP I Randomized Clinical Trial.

Kandzari DE, Weber MA, Pathak A, Zidar JP, Saxena M, David SW, Schmieder RE, Janas AJ, Langer C, Persu A, Mendelsohn FO, Ameloot K, Foster Iii M, Fischell TA, Parise H, Mahfoud F. Kandzari DE, et al. Among authors: parise h. Circulation. 2024 Apr 8. doi: 10.1161/CIRCULATIONAHA.124.069291. Online ahead of print. Circulation. 2024. PMID: 38587557

120

Budget Impact of Introducing Fixed-Duration Mosunetuzumab for the Treatment of Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy in the USA.

Lin SW, Shapouri S, Parisé H, Bercaw E, Wu M, Kim E, Matasar M. Lin SW, et al. Among authors: parise h. Pharmacoeconomics. 2024 May;42(5):569-582. doi: 10.1007/s40273-024-01358-y. Epub 2024 Feb 1. Pharmacoeconomics. 2024. PMID: 38300452 Free PMC article.

121

Predictors of Cerebral Embolic Debris During Transcatheter Aortic Valve Replacement: The SafePass 2 First-in-Human Study.

Grubman D, Ahmad Y, Leipsic JA, Blanke P, Pasupati S, Webster M, Nazif TM, Parise H, Lansky AJ. Grubman D, et al. Among authors: parise h. Am J Cardiol. 2023 Nov 15;207:28-34. doi: 10.1016/j.amjcard.2023.08.137. Epub 2023 Sep 16. Am J Cardiol. 2023. PMID: 37722198

122

Supervised Exercise Therapy Versus Percutaneous Transluminal Angioplasty for Claudication by Level of Disease: A Systematic Review and Meta-Analysis.

Kapadia S, Huang H, Parise H, Ismayl M, Ahmed Z, Tirziu D, Altin SE. Kapadia S, et al. Among authors: parise h. Am J Cardiol. 2023 Oct 15;205:403-405. doi: 10.1016/j.amjcard.2023.08.044. Epub 2023 Aug 31. Am J Cardiol. 2023. PMID: 37659260 No abstract available.

123

Effect of antecedent statin usage on conduction disturbances and arrhythmias after transcatheter aortic valve replacement.

Shah T, Maarek R, See C, Huang H, Wang Y, Parise H, Forrest JK, Lansky AJ. Shah T, et al. Among authors: parise h. Cardiovasc Revasc Med. 2024 Feb;59:3-8. doi: 10.1016/j.carrev.2023.07.022. Epub 2023 Jul 27. Cardiovasc Revasc Med. 2024. PMID: 37573173

124

Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication.

Altin SE, Parise H, Hess CN, Rosenthal NA, Creager MA, Aronow HD, Curtis JP. Altin SE, et al. Among authors: parise h. JACC Cardiovasc Interv. 2023 Jul 10;16(13):1668-1678. doi: 10.1016/j.jcin.2023.05.001. JACC Cardiovasc Interv. 2023. PMID: 37438035

125

Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications.

Pathak A, Rudolph UM, Saxena M, Zeller T, Müller-Ehmsen J, Lipsic E, Schmieder RE, Sievert H, Halbach M, Sharif F, Parise H, Fischell TA, Weber MA, Kandzari DE, Mahfoud F. Pathak A, et al. Among authors: parise h. EuroIntervention. 2023 Sep 18;19(7):602-611. doi: 10.4244/EIJ-D-23-00088. EuroIntervention. 2023. PMID: 37427416 Free article. Clinical Trial.

126

Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Diabetes: The Chocolate Touch Study.

Böhme T, Zeller T, Shishehbor MH, Werner M, Brodmann M, Parise H, Holden A, Lichtenberg M, Parikh SA, Kashyap VS, Pietras C, Tirziu D, Beschorner U, Krishnan P, Niazi KA, Wali AU, Lansky AJ. Böhme T, et al. Among authors: parise h. J Endovasc Ther. 2023 Jun 14:15266028231179589. doi: 10.1177/15266028231179589. Online ahead of print. J Endovasc Ther. 2023. PMID: 37314243

127

Impact of New-Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single-Center Study.

See C, Wang Y, Huang H, Parise H, Yang Y, Tirziu D, Francese DP, Papoutsidakis N, Bader E, Kaple RK, Cleman M, Lansky AJ, Forrest JK. See C, et al. Among authors: parise h. J Interv Cardiol. 2023 May 31;2023:5390338. doi: 10.1155/2023/5390338. eCollection 2023. J Interv Cardiol. 2023. PMID: 37292113 Free PMC article.

128

Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial.

Shah T, McCarthy M, Nasir I, Archer H, Ragheb E, Kluger J, Kashyap N, Paredes C, Patel P, Lu J, Kandel P, Song C, Khan M, Huang H, Ul Haq F, Ahmad R, Howes C, Cambi B, Lancaster G, Cleman M, Dela Cruz C, Parise H, Lansky A. Shah T, et al. Among authors: parise h. BMJ Open. 2023 Feb 24;13(2):e067910. doi: 10.1136/bmjopen-2022-067910. BMJ Open. 2023. PMID: 36828654 Free PMC article. Clinical Trial.

129

Implementation of supervised exercise therapy in a veteran population with symptomatic claudication.

Elissa Altin S, Schneider MD, Parise H, Banerjee S, Wu WC, Meadows JL, Pfau S, Keefe H, Armstrong EJ. Elissa Altin S, et al. Among authors: parise h. Vasc Med. 2022 Apr;27(2):136-141. doi: 10.1177/1358863X211073622. Epub 2022 Feb 28. Vasc Med. 2022. PMID: 35225695

130

Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States.

Cho SK, Manzoor BS, Sail KR, Parisé H, Ravelo A, Shapouri S, Kapustyan T, Sharmokh S, Virabhak S, Davids MS, Johnson S. Cho SK, et al. Among authors: parise h. Pharmacoeconomics. 2020 Sep;38(9):941-951. doi: 10.1007/s40273-020-00919-1. Pharmacoeconomics. 2020. PMID: 32383129

131

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.

Stone GW, Kappetein AP, Sabik JF, Pocock SJ, Morice MC, Puskas J, Kandzari DE, Karmpaliotis D, Brown WM 3rd, Lembo NJ, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogáts G, Mansour S, Noiseux N, Sabaté M, Pomar J, Hickey M, Gershlick A, Buszman PE, Bochenek A, Schampaert E, Pagé P, Modolo R, Gregson J, Simonton CA, Mehran R, Kosmidou I, Généreux P, Crowley A, Dressler O, Serruys PW; EXCEL Trial Investigators. Stone GW, et al. N Engl J Med. 2019 Nov 7;381(19):1820-1830. doi: 10.1056/NEJMoa1909406. Epub 2019 Sep 28. N Engl J Med. 2019. PMID: 31562798 Free article. Clinical Trial.

132

Cost Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in Colombia.

Parise H, Espinosa R, Dea K, Anaya P, Montoya G, Ng DB. Parise H, et al. Pharmacoecon Open. 2020 Mar;4(1):79-90. doi: 10.1007/s41669-019-0149-9. Pharmacoecon Open. 2020. PMID: 31168754 Free PMC article.

133

Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.

Stone GW, Sabik JF, Serruys PW, Simonton CA, Généreux P, Puskas J, Kandzari DE, Morice MC, Lembo N, Brown WM 3rd, Taggart DP, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogáts G, Mansour S, Noiseux N, Sabaté M, Pomar J, Hickey M, Gershlick A, Buszman P, Bochenek A, Schampaert E, Pagé P, Dressler O, Kosmidou I, Mehran R, Pocock SJ, Kappetein AP; EXCEL Trial Investigators. Stone GW, et al. N Engl J Med. 2016 Dec 8;375(23):2223-2235. doi: 10.1056/NEJMoa1610227. Epub 2016 Oct 31. N Engl J Med. 2016. PMID: 27797291 Free article. Clinical Trial.

134

Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States.

Saab S, Virabhak S, Parisé H, Johnson S, Wang A, Misurski D, Gonzalez YS, Juday T. Saab S, et al. Among authors: parise h. Adv Ther. 2016 Aug;33(8):1316-30. doi: 10.1007/s12325-016-0362-1. Epub 2016 Jun 24. Adv Ther. 2016. PMID: 27342742

135

Economic evaluation of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic genotype 1 hepatitis c virus infection.

Johnson SJ, Parisé H, Virabhak S, Filipovic I, Samp JC, Misurski D. Johnson SJ, et al. Among authors: parise h. J Med Econ. 2016 Oct;19(10):983-94. doi: 10.1080/13696998.2016.1189920. Epub 2016 May 30. J Med Econ. 2016. PMID: 27172133 Free article.

136

Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US.

Saab S, Parisé H, Virabhak S, Wang A, Marx SE, Sanchez Gonzalez Y, Misurski D, Johnson S. Saab S, et al. Among authors: parise h. J Med Econ. 2016 Aug;19(8):795-805. doi: 10.1080/13696998.2016.1176030. Epub 2016 Apr 24. J Med Econ. 2016. PMID: 27063573 Free article.

137

Evaluating the clinical usefulness of platelet function testing: considerations for the proper application and interpretation of performance measures.

Dahlen JR, Price MJ, Parise H, Gurbel PA. Dahlen JR, et al. Among authors: parise h. Thromb Haemost. 2013 May;109(5):808-16. doi: 10.1160/TH12-08-0608. Epub 2012 Dec 20. Thromb Haemost. 2013. PMID: 23254993 Review.

138

[Impact of building and finishing materials and new furniture on the occurrence of respiratory diseases in children].

Lebedeva NV, Furman VD, Kislitsin VA, Konygin EA, Zemlianaia GM, Koroleva MV, Jaakkola JJ, Parise H, Spengler J. Lebedeva NV, et al. Among authors: parise h. Gig Sanit. 2004 Jul-Aug;(4):49-53. Gig Sanit. 2004. PMID: 15318615 Russian.

139

[Influence of negative factors of the living environment on respiratory diseases in children].

Lebedeva NV, Furman VD, Kislitsa VA, Konygin EA, Zemlianaia GM, Koroleva MV, Jaakkola JK, Parise H, Spengler J. Lebedeva NV, et al. Among authors: parise h. Gig Sanit. 2004 May-Jun;(3):59-65. Gig Sanit. 2004. PMID: 15197863 Russian.

140

Housing characteristics and children's respiratory health in the Russian Federation.

Spengler JD, Jaakkola JJ, Parise H, Katsnelson BA, Privalova LI, Kosheleva AA. Spengler JD, et al. Among authors: parise h. Am J Public Health. 2004 Apr;94(4):657-62. doi: 10.2105/ajph.94.4.657. Am J Public Health. 2004. PMID: 15054021 Free PMC article.

141

Asthma, wheezing, and allergies in Russian schoolchildren in relation to new surface materials in the home.

Jaakkola JJ, Parise H, Kislitsin V, Lebedeva NI, Spengler JD. Jaakkola JJ, et al. Among authors: parise h. Am J Public Health. 2004 Apr;94(4):560-2. doi: 10.2105/ajph.94.4.560. Am J Public Health. 2004. PMID: 15054004 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page